Therefore, in this study, the serum levels and tissue expression of VEGF-A and its receptors, VEGFR-1 and VEGFR-2, were evaluated in cats with mammary carcinoma, in order to improve diagnostic tools and therapeutic strategies. The gene discussed is FLT1; the disease is breast carcinoma.